Therapeutic and Toxic Indexes of Digitalis
- 25 April 1957
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 256 (17) , 767-773
- https://doi.org/10.1056/nejm195704252561701
Abstract
IN recent years considerable interest has been aroused in the therapeutic-toxic ratios possessed by various digitalis preparations; among those evoking special interest is gitalin, the water-extractable substance of digitalis purpurea that was first studied by Kraft1 in 1912 and later by others in this country.2 3 4 More recent reports dealing with gitalin have indicated a wider therapeutic range as compared with other preparations such as digitoxin, digitalis leaf and Digoxin.5 6 7 8 9 10 It has been stated, for example, that the therapeutic dose of amorphous gitalin is approximately 40 per cent of the toxic dose, whereas other glycosides (digitoxin, digitalis leaf and Digoxin) studied . . .Keywords
This publication has 13 references indexed in Scilit:
- CLINICAL EVALUATION OF GITALIN IN THE TREATMENT OF CONGESTIVE HEART FAILUREAnnals of Internal Medicine, 1953
- Studies with intravenous gitalin. IAmerican Heart Journal, 1953
- A CLINICAL STUDY OF GITALINArchives of internal medicine (1960), 1952
- The Therapeutic Range of Gitalin (Amorphous) Compared with Other Digitalis PreparationsCirculation, 1952
- Studies with gitalin (amorphous) for the treatment of patients with congestive heart failureAmerican Heart Journal, 1951
- PharmacologyAnnual Review of Physiology, 1945
- Clinical studies of gitalin and of digitalis in the treatment of auricular fibrillationAmerican Heart Journal, 1938
- CLINICAL STUDIES ON VERODIGEN, A DIGITALIS GLUCOSIDEAnnals of Internal Medicine, 1936
- THE USE OF VERODIGEN (A DIGITALIS GLUCOSIDE) IN CARDIOVASCULAR DISEASE, ITS BIOLOGICAL ASSAY, AND PHARMACOLOGICAL ACTIONAnnals of Internal Medicine, 1934
- Die Glykoside der Blätter der Digitalis purpureaArchiv der Pharmazie, 1912